178 related articles for article (PubMed ID: 38213329)
1. Antigen presentation deficiency, mesenchymal differentiation, and resistance to immunotherapy in the murine syngeneic CT2A tumor model.
Iorgulescu JB; Ruthen N; Ahn R; Panagioti E; Gokhale PC; Neagu M; Speranza MC; Eschle BK; Soroko KM; Piranlioglu R; Datta M; Krishnan S; Yates KB; Baker GJ; Jain RK; Suvà ML; Neuberg D; White FM; Chiocca EA; Freeman GJ; Sharpe AH; Wu CJ; Reardon DA
Front Immunol; 2023; 14():1297932. PubMed ID: 38213329
[TBL] [Abstract][Full Text] [Related]
2. Technical choices significantly alter the adaptive immune response against immunocompetent murine gliomas in a model-dependent manner.
Noffsinger B; Witter A; Sheybani N; Xiao A; Manigat L; Zhong Q; Taori S; Harris T; Bullock T; Price R; Purow B
J Neurooncol; 2021 Sep; 154(2):145-157. PubMed ID: 34432197
[TBL] [Abstract][Full Text] [Related]
3. Treatment of an aggressive orthotopic murine glioblastoma model with combination checkpoint blockade and a multivalent neoantigen vaccine.
Liu CJ; Schaettler M; Blaha DT; Bowman-Kirigin JA; Kobayashi DK; Livingstone AJ; Bender D; Miller CA; Kranz DM; Johanns TM; Dunn GP
Neuro Oncol; 2020 Sep; 22(9):1276-1288. PubMed ID: 32133512
[TBL] [Abstract][Full Text] [Related]
4. Stable luciferase expression does not alter immunologic or in vivo growth properties of GL261 murine glioma cells.
Clark AJ; Safaee M; Oh T; Ivan ME; Parimi V; Hashizume R; Ozawa T; James CD; Bloch O; Parsa AT
J Transl Med; 2014 Dec; 12():345. PubMed ID: 25464980
[TBL] [Abstract][Full Text] [Related]
5. Impact of CD4 T cells on intratumoral CD8 T-cell exhaustion and responsiveness to PD-1 blockade therapy in mouse brain tumors.
Khan SM; Desai R; Coxon A; Livingstone A; Dunn GP; Petti A; Johanns TM
J Immunother Cancer; 2022 Dec; 10(12):. PubMed ID: 36543376
[TBL] [Abstract][Full Text] [Related]
6. Tumor-targeted interleukin-12 synergizes with entinostat to overcome PD-1/PD-L1 blockade-resistant tumors harboring MHC-I and APM deficiencies.
Minnar CM; Chariou PL; Horn LA; Hicks KC; Palena C; Schlom J; Gameiro SR
J Immunother Cancer; 2022 Jun; 10(6):. PubMed ID: 35764364
[TBL] [Abstract][Full Text] [Related]
7. Dysregulation in IFN-γ signaling and response: the barricade to tumor immunotherapy.
Han J; Wu M; Liu Z
Front Immunol; 2023; 14():1190333. PubMed ID: 37275859
[TBL] [Abstract][Full Text] [Related]
8. CXCL10 and Nrf2-upregulated mesenchymal stem cells reinvigorate T lymphocytes for combating glioblastoma.
Mao J; Li J; Chen J; Wen Q; Cao M; Zhang F; Li B; Zhang Q; Wang Z; Zhang J; Shen J
J Immunother Cancer; 2023 Dec; 11(12):. PubMed ID: 38056897
[TBL] [Abstract][Full Text] [Related]
9. Loss of interferon-gamma inducibility of TAP1 and LMP2 in a renal cell carcinoma cell line.
Dovhey SE; Ghosh NS; Wright KL
Cancer Res; 2000 Oct; 60(20):5789-96. PubMed ID: 11059775
[TBL] [Abstract][Full Text] [Related]
10. The mutation in the ATP-binding region of JAK1, identified in human uterine leiomyosarcomas, results in defective interferon-gamma inducibility of TAP1 and LMP2.
Hayashi T; Kobayashi Y; Kohsaka S; Sano K
Oncogene; 2006 Jul; 25(29):4016-26. PubMed ID: 16474838
[TBL] [Abstract][Full Text] [Related]
11. Interferon Alpha Signalling and Its Relevance for the Upregulatory Effect of Transporter Proteins Associated with Antigen Processing (TAP) in Patients with Malignant Melanoma.
Heise R; Amann PM; Ensslen S; Marquardt Y; Czaja K; Joussen S; Beer D; Abele R; Plewnia G; Tampé R; Merk HF; Hermanns HM; Baron JM
PLoS One; 2016; 11(1):e0146325. PubMed ID: 26735690
[TBL] [Abstract][Full Text] [Related]
12. LDH-A-Modulation and the Variability of LDH Isoenzyme Profiles in Murine Gliomas: A Link with Metabolic and Growth Responses.
Shindo M; Maeda M; Myat K; Mane MM; Cohen IJ; Vemuri K; Albeg AS; Serganova I; Blasberg R
Cancers (Basel); 2022 May; 14(9):. PubMed ID: 35565432
[TBL] [Abstract][Full Text] [Related]
13. Uncoupling interferon signaling and antigen presentation to overcome immunotherapy resistance due to JAK1 loss in melanoma.
Kalbasi A; Tariveranmoshabad M; Hakimi K; Kremer S; Campbell KM; Funes JM; Vega-Crespo A; Parisi G; Champekar A; Nguyen C; Torrejon D; Shin D; Zaretsky JM; Damoiseaux RD; Speiser DE; Lopez-Casas PP; Quintero M; Ribas A
Sci Transl Med; 2020 Oct; 12(565):. PubMed ID: 33055240
[TBL] [Abstract][Full Text] [Related]
14. Pan-cancer analysis: predictive role of TAP1 in cancer prognosis and response to immunotherapy.
Tu Z; Li K; Ji Q; Huang Y; Lv S; Li J; Wu L; Huang K; Zhu X
BMC Cancer; 2023 Feb; 23(1):133. PubMed ID: 36759763
[TBL] [Abstract][Full Text] [Related]
15. Anti-PD-1 and Extended Half-life IL2 Synergize for Treatment of Murine Glioblastoma Independent of Host MHC Class I Expression.
Tritz ZP; Ayasoufi K; Wolf DM; Owens CA; Malo CS; Himes BT; Fain CE; Goddery EN; Yokanovich LT; Jin F; Hansen MJ; Parney IF; Wang C; Moynihan KD; Irvine DJ; Wittrup KD; Diaz Marcano RM; Vile RG; Johnson AJ
Cancer Immunol Res; 2023 Jun; 11(6):763-776. PubMed ID: 36921098
[TBL] [Abstract][Full Text] [Related]
16. Loss of interferon-gamma inducibility of the MHC class II antigen processing pathway in head and neck cancer: evidence for post-transcriptional as well as epigenetic regulation.
Meissner M; Whiteside TL; van Kuik-Romein P; Valesky EM; van den Elsen PJ; Kaufmann R; Seliger B
Br J Dermatol; 2008 May; 158(5):930-40. PubMed ID: 18284388
[TBL] [Abstract][Full Text] [Related]
17. Distinct mechanisms of loss of IFN-gamma mediated HLA class I inducibility in two melanoma cell lines.
Rodríguez T; Méndez R; Del Campo A; Jiménez P; Aptsiauri N; Garrido F; Ruiz-Cabello F
BMC Cancer; 2007 Feb; 7():34. PubMed ID: 17319941
[TBL] [Abstract][Full Text] [Related]
18. Association of IFN-gamma signal transduction defects with impaired HLA class I antigen processing in melanoma cell lines.
Respa A; Bukur J; Ferrone S; Pawelec G; Zhao Y; Wang E; Marincola FM; Seliger B
Clin Cancer Res; 2011 May; 17(9):2668-78. PubMed ID: 21248298
[TBL] [Abstract][Full Text] [Related]
19. PD-L1 expression is mainly regulated by interferon gamma associated with JAK-STAT pathway in gastric cancer.
Mimura K; Teh JL; Okayama H; Shiraishi K; Kua LF; Koh V; Smoot DT; Ashktorab H; Oike T; Suzuki Y; Fazreen Z; Asuncion BR; Shabbir A; Yong WP; So J; Soong R; Kono K
Cancer Sci; 2018 Jan; 109(1):43-53. PubMed ID: 29034543
[TBL] [Abstract][Full Text] [Related]
20. Intracranial implantation with subsequent 3D in vivo bioluminescent imaging of murine gliomas.
Abdelwahab MG; Sankar T; Preul MC; Scheck AC
J Vis Exp; 2011 Nov; (57):e3403. PubMed ID: 22158303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]